Private investment major Apollo Global Management has taken a stake in Swiss dental company vVardis Holding AG in a transaction that values the business at more than $1bn, according to a company statement.
The investment leaves founders and co-CEOs Haley and Goly Abivardi with an approximate 70% ownership position, according to people familiar with the deal.
vVardis specialises in non-invasive dental treatments, particularly targeting early-stage tooth decay. Its core technology, Curodont, is a peptide-based solution designed to penetrate enamel and support natural remineralisation, offering an alternative to traditional drilling procedures.
Apollo said the investment will support the company’s growth across key markets in the US and Europe, with a focus on expanding access to its restorative therapies among dental practitioners and patients.
The company has positioned itself within a niche segment of the dental market by promoting a shift away from surgical interventions toward preventative and regenerative care. Its products are already in use across a growing share of dental practices, particularly in the US, and the business has also established a presence in the Middle East.
Investor interest in vVardis has increased in recent years, with early backing from figures including David Wertheimer and family office Duxebridge Capital.
